H2O Innovation Strengthens its Health & Safety Program and Earns ISO Certifications for Genesys
March 2, 2021 (Source) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce that one of its specialty chemicals business lines, Genesys, has obtained two new ISO certifications, demonstrating its continued commitment to respecting and promoting health and safety at work.
As part of the Corporation’s 3-Year Strategic Plan announced a few months ago, one of the main objectives was to create a safer working environment with top tier health, safety and environmental (“HSE”) practices. The well-being of the Corporation’s employees and the protection of the environment are priorities for H2O Innovation and essential to its strong culture. “Some high-profile industrial clients even require suppliers to adopt best practices with regards to environmental, social and governance (“ESG”) factors and HSE. Focusing on continuous improvement in these areas should enable us to raise our profile as a supplier and differentiate ourselves from the competition,” stated Frédéric Dugré, President and CEO of H2O Innovation.
The UK-based Genesys team has been granted two ISO certifications in the past few weeks. The first, ISO 22301, ensures that the team can operate efficiently despite interruptions like COVID-19. This certification signals the focus on best practices with respect to business continuity. Because of procedures in place, Genesys continues to deliver its specialty chemicals from its facilities in Cheshire, UK, to more than 75 countries around the world. The second certification, ISO 45001, promotes physical and mental health with the goal of reducing injuries work absenteeism. These are two specific examples of the Corporation’s renewed focus on its employees and customers.
H2O Innovation has also recently implemented Sospes software to facilitate the tracking and continuous improvement of the overall safety rating of the Corporation as a company. The goal is to reduce potential for injuries to employees as well as empower and encourage teams to work safely. “We have had a strong safety culture at H2O Innovation, and the latest efforts are not only a testament to that, but also show our desire to standardize and push best practices across all our business units. These initiatives to improve the safety of our employees will help make us an employer of choice,” added Gregory Madden, Chief Strategic Officer of H2O Innovation.
This press release contains forward-looking information under applicable securities law. All information that addresses operations and activities that H2O Innovation expects to occur in the future is forward-looking information. Forward-looking statements use such words as “believe”, “continue”, “estimate”, “expect”, “intend”, “should” or “will” and other similar terms as well as those usually used in the future and the conditional. Forward-looking statements concern analysis and other information based on forecast future results and the estimate of amounts that cannot yet be determined and are based on the estimates and opinions of management on the date the statements are made. Those forward-looking statements involve several risks and uncertainties. Those risks and uncertainties include, but are not limited to, the Corporation’s ability to maintain this cross-business collaboration, increase recurring sales following new business wins and improve gross profit margin. Other risk factors are discussed in the Corporation’s Annual Information Form dated September 23, 2020 available on SEDAR (www.sedar.com).
Should one or more of these risks or uncertainties materialize, or should the assumptions underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. Unless required to do so pursuant to applicable securities legislation, H2O Innovation assumes no obligation to update or revise forward-looking statements contained in this press release or in other communications as a result of new information, future events, and other changes.
Genesys is a UK privately-owned group of companies specializing in the development and manufacturing of specialty chemicals dedicated to water treatment. Genesys develops, manufactures and distributes specialty reverse osmosis (RO) membrane chemicals, antiscalants, cleaners, flocculants and biocides, and offers, through a large distribution network, a portfolio of over 35 diversified products with unique formulation that are manufactured in its facility located in Cheshire, UK. In addition, Genesys also offers complete laboratory services such as feed water and pre-treatment tests, membrane autopsies and cleaning program design. For more information, visit www.genesysro.com.
About H2O Innovation
H2O Innovation designs and provides state-of-the-art, custom-built, and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation’s activities rely on three pillars which are i) water technologies and services; ii) specialty products, including a complete line of specialty chemicals, consumables, and specialized products for the water treatment industry; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit www.h2oinnovation.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the NYSE Euronext Growth Paris accepts responsibility for the adequacy or accuracy of this release.